Offer extended until 31 July 2026: get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
Is QP Certification required when Products do not enter EU Territory?
Recommendation
8/9 October 2026
Understand the Implications of becoming a QP
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Medicines Agency (EMA) has published a new Q&A addressing the requirement for Qualified Person (QP) certification of batches that are neither manufactured in the EU/EEA nor intended for the EU/EEA market and are not physically imported into the EU/EEA.
In such cases, QP certification does not fall under EU legislation. This would only apply if the medicinal products were intended for the EU market or were to be used in clinical trials within the EU/EEA.. Consequently, these activities are not subject to authorisation under a manufacturing or import authorisation, nor are they subject to inspection by EU National Competent Authorities.
Accordingly, references to EU legislation should not be included in documentation related to the batch release of medicinal product batches that are not manufactured in the EU/EEA, not intended for supply to EU/EEA countries, and not physically imported into the EU/EEA.
The Q&A can be found in the section on Annex 16 on the Agency website.
Related GMP News
01.07.2026EMA publishes updated Q&A on EU-US MRA - Veterinary Medicinal Products now fully covered
24.06.2026Reduced Testing a Matter of GMP or Specification?
17.06.2026FDA adopts updated ICH Q8/Q9/Q10 Questions & Answers (R5)
10.06.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated